Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Respiratory and Critical Care Medicine|March 27, 2014
Pulmonary involvement in Sjögren syndromeMaryl Kreider, Kristin Highland
Cleveland Clinic Journal of Medicine|May 13, 2020
Recognition and management of respiratory co-infection and secondary bacterial pneumonia in patients with COVID-19Chao-Ping Wu, Fatima Adhi, Kristin Highland
Chest|July 14, 2004
Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhageS Hinan Ahmed, Tariq Aziz, Joel Cochran, et al.
Lung|August 25, 2007
Interstitial lung disease in systemic sclerosisPredrag Ostojic, Marco Matucci Cerinic, Richard Silver, et al.
Arthritis and Rheumatism|March 24, 2010
Dihydrosphingosine 1-phosphate has a potent antifibrotic effect in scleroderma fibroblasts via normalization of phosphatase and tensin homolog levelsShizhong Bu, Yoshihide Asano, Andreea Bujor, et al.
The American Journal of Pathology|March 16, 2010
Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathyYoshihide Asano, Lukasz Stawski, Faye Hant, et al.
Respiratory Medicine|December 9, 2022
Effects of COVID-19 pandemic on the management of pulmonary hypertensionChristine Y Zhou, Sandeep Sahay, Oksana Shlobin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 3, 2021
ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statementsMaria M Crespo, Tamara Claridge, Robyn T Domsic, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
Pageof 1